Given that NCAM1 regulates EV uptake through cell adhesion mechanisms and NCAM1-mimetic peptides have anti-inflammatory properties45, NCAM1-targeting strategies is a promising avenue for tauopathy intervention, particular in APOE4 carriers. This evidence concerns the gene NCAM1 and tauopathy.